Cognitive behavioral and pharmacological treatments of OCD in children: A systematic review and meta-analysis

Journal of Anxiety Disorders

Volumn 43, Issue , 2016, Pages 58-69

  Öst, Lars Göran ^a,b,c   Riise, Eili N ^c,d   Wergeland, Gro Janne ^d   Hansen, Bjarne ^c,d   Kvale, Gerd ^c,d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b STOCKHOLM UNIVERSITY   (Sweden)

^c UNIVERSITY OF BERGEN   (Norway)

^d HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Children; Cognitive therapy; Exposure and response prevention; Meta analysis; Obsessive compulsive disorder; Systematic review

Indexed keywords

CLOMIPRAMINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

CHILD HEALTH CARE; COGNITIVE BEHAVIORAL THERAPY; DISEASE SEVERITY; DRUG EFFICACY; HUMAN; MENTAL HEALTH; META ANALYSIS; OBSESSIVE COMPULSIVE DISORDER; PARENTAL BEHAVIOR; PATIENT PARTICIPATION; PSYCHOLOGICAL RATING SCALE; PSYCHOTHERAPY; RELIABILITY; REMISSION; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT PLANNING; TREATMENT REFUSAL; TREATMENT RESPONSE; YALE BROWN OBSESSIVE COMPULSIVE SCALE; ADOLESCENT; CHILD; COGNITIVE THERAPY; MULTIMODALITY CANCER THERAPY; OBSESSIVE-COMPULSIVE DISORDER; PROCEDURES; PSYCHOLOGY;

ADOLESCENT; CHILD; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; HUMANS; OBSESSIVE-COMPULSIVE DISORDER; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 84986921930     PISSN: 08876185     EISSN: 18737897     Source Type: Journal    
DOI: 10.1016/j.janxdis.2016.08.003     Document Type: Review

References (51)

1. AACAP, Practice parameter for the assessment and treatment of children and adolescents with obsessive-compulsive disorder. Journal of the American Academy of Child & Adolescent Psychiatry 51:1 (2012), 98–113, 10.1016/j.jaac.2011.09.019.
2. Abramowitz, J.S., Whiteside, S.P., Deacon, B.J., The effectiveness of treatment for pediatric obsessive-compulsive disorder: A meta-analysis. Behavior Therapy 36:1 (2005), 55–63, 10.1016/S0005-7894(05)80054-1.
3. Asbahr, F.R., Castillo, A.R., Ito, L.M., Latorre, M.R.D.d.O., Moreira, M.N., Lotufo-Neto, F., Group cognitive-behavioral therapy versus sertraline for the treatment of children and adolescents with obsessive-compulsive disorder. Journal of the American Academy of Child & Adolescent Psychiatry 44:11 (2005), 1128–1136, 10.1097/01.chi.0000177324.40005.6f.
4. Barrett, P., Healy-Farrell, L., March, J.S., Cognitive-behavioral family treatment of childhood obsessive-compulsive disorder: A controlled trial. Journal of the American Academy of Child & Adolescent Psychiatry 43:1 (2004), 46–62, 10.1097/00004583-200401000-00014.
5. Biostat Inc, Comprehensive meta-analysis, version 2. Statistical software. 2006, Biostat Inc., Englewood, NJ.
6. Bolton, D., Perrin, S., Evaluation of exposure with response-prevention for obsessive compulsive disorder in childhood and adolescence. Journal of Behavior Therapy and Experimental Psychiatry 39 (2008), 11–22, 10.1016/j.jbtep.2006.11.002.
7. Bolton, D., Williams, T., Perrin, S., Atkinson, L., Gallop, C., Waite, P., Salkovskis, P., Randomized controlled trial of full and brief cognitive-behaviour therapy and wait-list for paediatric obsessive-compulsive disorder. Journal of Child Psychology and Psychiatry 52 (2011), 1269–1278, 10.1111/j. 1469–7610.2011.02419.x.
8. Canals, J., Hernández-Martínez, C., Cosi, S., Voltas, N., The epidemiology of obsessive—Compulsive disorder in Spanish school children. Journal of Anxiety Disorders 26:7 (2012), 746–752, 10.1016/j.janxdis.2012.06.003.
9. DeVeaugh-Geiss, J., Moroz, G., Biederman, J., Cantwell, D., Fontaine, R., Greist,. Landau, P., Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder—a multicenter trial. Journal of the American Academy of Child and Adolescent Psychiatry 31 (1992), 45–49, 10.1097/00004583-199201000-00008.
10. Duval, S., Tweedie, R., Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56:2 (2000), 455–463, 10.1111/j.0006-341X.2000.00455.x.
11. Egger, M., Davey Smith, G., Schneider, M., Minder, C., Bias in meta-analysis detected by a simple, graphical test. British Medical Journal 315:7109 (1997), 629–634, 10.1136/bmj.316.7129.469.
12. Farrell, L.J., Waters, A.M., Boschen, M.J., Hattingh, L., McConnell, H., Milliner, E.L.,. Storch, E.A., Difficult-to-treat pediatric obsessive-compulsive disorder: Feasibility and preliminary results of a randomized pilot trial of D-cycloserine-augmented behavior therapy. Depression and Anxiety 30 (2013), 723–731, 10.1002/da.22132.
13. Franklin, M.E., Sapyta, J., Freeman, J.B., Khanna, M., Compton, S., Almirall, D.,. March, J.S., Cognitive behavior therapy augmentation of pharmacotherapy in pediatric obsessive-compulsive disorder: The pediatric OCD treatment study II (POTS II) randomized controlled trial. JAMA 306 (2011), 1224–1232, 10.1001/jama.2011.1344.
14. Freeman, J.B., Choate-Summers, M.L., Moore, P.S., Garcia, A.M., Sapyta, J.J., Leonard, H.L., Franklin, M.E., Cognitive behavioral treatment for young children with obsessive-compulsive disorder. Biological Psychiatry 61:3 (2007), 337–343, 10.1016/j.biopsych.2006.12.015.
15. Geller, D., Biederman, J.J., Faraone, J.S., Agranat, J.A., Cradock, J.K., Hagermoser, J.L., Coffey, J.B., Developmental aspects of obsessive compulsive disorder: Findings in children, adolescents, and adults. The Journal of Nervous and Mental Disease 189:7 (2001), 471–477, 10.1097/00005053-200107000-00009.
16. Geller, D., Biederman, J., Faraone, S.V., Frazier, J., Coffey, B.J., Kim, G., Bellordre, C.A., Clinical correlates of obsessive compulsive disorder in children and adolescents referred to specialized and non-specialized clinical settings. Depression and Anxiety 11:4 (2000), 163–168, 10.1002/1520-6394(2000)11:4<163:AID-DA3>3.0.CO;2-3.
17. Geller, D.A., Hoog, S.L., Heiligenstein, J.H., Ricardi, R.K., Tamura, R., Kluszynski, S., Jacobson, J.G., Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: A placebo-controlled clinical trial. Journal of the American Academy of Child & Adolescent Psychiatry 40 (2001), 773–779, 10.1097/00004583-200107000-00011.
18. Geller, D.A., Wagner, K.D., Emslie, G., Murphy, T., Carpenter, D.J., Wetherhold, E.,. Gardiner, C., Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: A randomized, multicenter, double-blind, placebo-controlled trial. Journal of the American Academy of Child & Adolescent Psychiatry 43 (2004), 1387–1396, 10.1097/01.chi.0000138356.29099.f1.
19. Higgins, J.P.T., Altman, D.G., Sterne, J.A.C., Chapter 8: Assessing risk of bias in included studies. Higgins, J.P.T., Green, S., (eds.) Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011], 2011, The Cochrane Collaboration.
20. Ivarsson, T., Skarphedinsson, G., Kornør, H., Axelsdottir, B., Biedilæ, S., Heyman, I.,. March, J., The place of and evidence for serotonin reuptake inhibitors (SRIs) for obsessive compulsive disorder (OCD) in children and adolescents: Views based on a systematic review and meta-analysis. Psychiatry Research 227 (2015), 93–103, 10.1016/j.psychres.2015.01.015.
21. Lewin, A.B., McGuire, J.F., Murphy, T.K., Storch, E.A., Editorial perspective: The importance of considering parent's preferences when planning treatment for their children—the case of childhood obsessive-compulsive disorder. Journal of Child Psychology and Psychiatry 55:12 (2014), 1314–1316, 10.1111/jcpp.12344.
22. Lewin, A.B., Park, J.M., Jones, A.M., Crawford, E.A., DeNadai, A.S., Menzel, J.,. Storch, E.A., Family-based exposure and response prevention therapy for preschool-aged children with obsessive-compulsive disorder: A pilot randomized controlled trial. Behaviour Research and Therapy 56 (2014), 30–38, 10.1016/j.brat.2014.02.001.
23. Liberati, A., Altman, D.G., Tetzlaff, J., Mulrow, C., Gotsche, P.C., Ioannidis, J.P.A.,. Moher, D., The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. PLoS Medicine, 6, 2009, e1000100, 10.7326/0003-4819-151-4-200908180-00136.
24. Lipsey, M.W., Wilson, D.B., Practical meta-analysis. 2001, Sage Publications, Thousand Oaks, CA.
25. March, J.S., Biederman, J., Wolkow, R., Safferman, A., Mardekian, J., Cook, E.H.,. Wagner, K.D., Sertraline in children and adolescents with obsessive-compulsive disorder: A multicenter randomized controlled trial. JAMA 280 (1998), 1752–1756, 10.1001/jama.280.20.1752.
26. March, J.S., Johnston, H., Jefferson, J.W., Kobak, K.A., Greist, J.H., Do subtle neurological impairments predict treatment resistance to clomipramine in children and adolescents with obsessive-compulsive disorder?. Journal of Child and Adolescent Psychopharmacology 1 (1990), 133–140, 10.1089/cap.1990.1.133.
27. Mataix-Cols, D., Fernandez de la Cruz, L., Nordsleten, A.E., Lenhard, F., Isomura, K., Simpson, H.B., Towards an international expert consensus for defining treatment response, remission, recovery, and relapse in obsessive-compulsive disorder: A Delphi survey. World Psychiatry, 2016 (in press).
28. McGuire, J.F., Piacentini, J., Lewin, A.B., Brennan, E.A., Murphy, T.K., Storch, E.A., A meta-analysis of cognitive behavior therapy and medication for child obsessive-compulsive disorder: Moderators of treatment efficacy, response, and remission. Depression and Anxiety 32:8 (2015), 580–593, 10.1002/da.22389.
29. Micali, N., Heyman, I., Perez, M., Hilton, K., Nakatani, E., Turner, C., Mataix-Cols, D., Long-term outcomes of obsessive-compulsive disorder: Follow-up of 142 children and adolescents. British Journal of Psychiatry 197:2 (2010), 128–134, 10.1192/bjp.bp.109.075317.
30. Moncrieff, J., Churchill, R., Drummond, D.C., McGuire, H., Development of a quality assessment instrument for trials of treatments for depression and neurosis. International Journal of Methods in Psychiatric Research 10:3 (2001), 126–133, 10.1002/mpr.108.
31. Morris, S.B., DeShon, R.P., Combining effect size estimates inmeta-analysis with repeated measures and independent-groups designs. Psychological Methods 7:1 (2002), 105–125, 10.1037/1082-989X.7.1.105.
32. NICE, Obsessive-compulsive disorder: core interventions in the treatment of obsessive-compulsive disorder and body dysmorphic disorder. 2005 Retrieved from: https://www.nice.org.uk/guidance/cg31.
33. Neziroglu, F., Yaryura-Tobias, J.A., Walz, J., McKay, D., The effect of fluvoxamine and behavior therapy on children and adolescents with obsessive-compulsive disorder. Journal of Child and Adolescent Psychopharmacology 10:4 (2000), 295–306, 10.1089/cap.2000.10.295.
34. O'Kearney, R.T., Anstey, K.J., Von Sanden, C., Hunt, A., Behavioural and cognitive behavioural therapy for obsessive compulsive disorder in children and adolescents. Cochrane Database of Systematic Reviews, 4, 2006, 10.1002/14651858.CD004856.pub2.
35. Öst, L.-G., Efficacy of the third wave of behavioral therapies: A systematic review and meta-analysis. Behaviour Research and Therapy 46:3 (2008), 296–321, 10.1016/j.brat.2007.12.005.
36. Öst, L.G., The efficacy of acceptance and commitment therapy: An updated systematic review and meta-analysis. Behaviour Research and Therapy 61 (2014), 105–121, 10.1016/j.brat.2014.07.018.
37. Öst, L.-G., Havnen, A., Hansen, B., Kvale, G., Cognitive behavioral treatments of obsessive-compulsive disorder. A systematic review and meta-analysis of studies published 1993–2014. Clinical Psychology Review 40 (2015), 156–169, 10.1016/j.cpr.2015.06.003.
38. Pediatric OCD Treatment Study Team, Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: The pediatric OCD treatment study (POTS) randomized controlled trial. JAMA 292 (2004), 1969–1976, 10.1001/jama.292.16.1969.
39. Peris, T.S., Piacentini, J., Optimizing treatment for complex cases of childhood obsessive compulsive disorder: A preliminary trial. Journal of Clinical Child and Adolescent Psychology 42 (2013), 1–8, 10.1080/15374416.2012.673162.
40. Piacentini, J., Bergman, R.L., Keller, M., McCracken, J., Functional impairment in children and adolescents with obsessive-compulsive disorder. Journal of Child and Adolescent Psychopharmacology 13:Suppl. 1 (2003), 61–69, 10.1089/104454603322126359.
41. Rasmussen, S.A., Epidemiology of obsessive compulsive disorder. Journal of Clinical Psychiatry 51:Suppl. S (1990), 10–13 http://www.ncbi.nlm.nih.gov/pubmed/2404965.
42. Reynolds, S.A., Clark, S., Smith, H., Langdon, P.E., Payne, R., Bowers,. McIlwham, H., Randomized controlled trial of parent-enhanced CBT compared with individual CBT for obsessive-compulsive disorder in young people. Journal of Consulting and Clinical Psychology 81 (2013), 1021–1026, 10.1037/a0034429.
43. Sánchez-Meca, J., Rosa-Alcázar, I., Iniesta-Sepúlveda, M., Rosa-Alcázar, Differential efficacy of cognitive-behavioral therapy and pharmacological treatments for pediatric obsessive-compulsive disorder: A meta-analysis. Journal of Anxiety Disorders 28:1 (2014), 31–44, 10.1016/j.janxdis.2013.10.007.
44. Scahill, L., Riddle, M.A., McSwiggin-Hardin, M., Ort, S.I., Children's Yale–Brown obsessive compulsive scale: Reliability and validity. Journal of the American Academy of Child & Adolescent Psychiatry 36 (1997), 844–852, 10.1097/00004583-199706000-00023.
45. Skarphedinsson, G., Hanssen-Bauer, K., Kornør, H., Heiervang, E.R., Landrø, N.I., Axelsdottir, B.,. Ivarsson, T., Standard individual cognitive behaviour therapy for paediatric obsessive-compulsive disorder: A systematic review of effect estimates across comparisons. Nordic Journal of Psychiatry 69:2 (2014), 81–92, 10.3109/08039488.2014.941395.
46. Skarphedinsson, G., Weidle, B., Thomsen, P., Dahl, K., Torp, N., Nissen, J.,. Ivarsson, T., Continued cognitive-behavior therapy versus sertraline for children and adolescents with obsessive–compulsive disorder that were non-responders to cognitive-behavior therapy: A randomized controlled trial. European Child & Adolescent Psychiatry 24:5 (2015), 591–602, 10.1007/s00787-014-0613-0.
47. Stewart, S.E., Geller, D.A., Jenike, M., Pauls, D., Shaw, D., Mullin, B., Faraone, S.V., Long-term outcome of pediatric obsessive-compulsive disorder: A meta-analysis and qualitative review of the literature. Acta Psychiatrica Scandinavica 110:1 (2004), 4–13, 10.1111/j.1600-0447.2004.00302.x.
48. Storch, E.A., Bussing, R., Small, B.J., Geffken, G.R., McNamara, J.P., Rahman, O.,. Murphy, T.K., Randomized, placebo-controlled trial of cognitive-behavioral therapy alone or combined with sertraline in the treatment of pediatric obsessive-compulsive disorder. Behaviour Research and Therapy 51 (2013), 823–829, 10.1016/j.brat.2013.09.007.
49. Thulin, U., Svirsky, L., Serlachius, E., Andersson, G., Öst, L.-G., The effect of parent involvement in the treatment of anxiety disorders in children: A meta-analysis. Cognitive Behaviour Therapy 43:3 (2014), 185–200, 10.1080/16506073.2014.923928.
50. Watson, H.J., Rees, C.S., Meta-analysis of randomized, controlled treatment trials for pediatric obsessive-compulsive disorder. Journal of Child Psychology and Psychiatry 49:5 (2008), 489–498, 10.1111/j.1469-7610.2007.01875.x.
51. Zohar, A.H., The epidemiology of obsessive-compulsive disorder in children and adolescents. Child and Adolescent Psychiatric Clinics of North America 8:3 (1999), 445–460 ncbi.nlm.nih.gov/pubmed/10442225.